Active, Not Recruiting
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
NCT05957510
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Guangdong Provincial Perople's Hospital Guangzhou, Guangdong, China